Vaccine major Oxford-Astrazeneca found itself in hot waters recently after Denmark ordered the suspension of its vaccine after some of the beneficiaries developed strange side-effects, including some blood clots.

Vaccine major Oxford-Astrazeneca found itself in hot waters recently after Denmark ordered the suspension of its vaccine after some of the beneficiaries developed strange side-effects, including some blood clots.